Progression of aortic pulse wave velocity in patients with chronic kidney disease

Susanne Tholen1, Katharina Klofat, Cheng Rui Pan

  • 1Department of Nephrology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

Insights

Arterial stiffness, measured by aortic pulse wave velocity (aPWV), significantly worsens in chronic kidney disease (CKD) patients over one year. Age, blood pressure, and diabetes accelerate this progression, highlighting cardiovascular risk factors in CKD.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Medical Science

Background:

  • Aortic pulse wave velocity (aPWV) is elevated in chronic kidney disease (CKD) patients, indicating increased cardiovascular risk.
  • The natural progression of arterial stiffness and its determinants in CKD patients are not fully understood.

Purpose of the Study:

  • To investigate the progression of aPWV in CKD patients over 12 months.
  • To identify factors associated with the acceleration of aPWV progression in this cohort.

Main Methods:

  • aPWV was measured in 70 CKD patients at baseline and after 12 months.
  • Correlations were analyzed between aPWV changes and variables including glomerular filtration rate reduction and diabetes mellitus.
  • Patients were divided into stable and progressive aPWV groups to identify associated factors.

Main Results:

  • aPWV significantly increased by 1.1 m/s in the cohort over 1 year (P<.01).
  • Accelerated aPWV progression was associated with older age, higher systolic blood pressure, and diabetes mellitus.
  • The rate of renal function decline (glomerular filtration rate reduction) did not significantly impact aPWV progression.

Conclusions:

  • Annual aPWV progression in CKD patients averages 1 m/s, signifying heightened cardiovascular risk.
  • Age, systolic blood pressure, and diabetes are key factors driving arterial stiffness progression in CKD.
  • Further research is needed to evaluate variables contributing to progressive arterial stiffness in CKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961